Analyst Price Targets — ILMN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 19, 2026 11:38 am | — | Canaccord Genuity | $300.00 | $262.54 | TheFly | Illumina price target raised to $300 from $205 at Canaccord |
| October 7, 2026 9:49 am | — | Barclays | $200.00 | $273.54 | TheFly | Illumina price target raised to $200 from $160 at Barclays |
| October 1, 2026 12:27 pm | Subbu Nambi | Guggenheim | $305.00 | $270.81 | TheFly | Illumina price target raised to $305 from $226 at Guggenheim |
| September 29, 2026 12:48 pm | — | Leerink Partners | $300.00 | $273.63 | TheFly | Illumina price target raised to $300 from $220 at Leerink |
| September 28, 2026 10:46 am | David Westenberg | Piper Sandler | $305.00 | $270.00 | TheFly | Illumina price target raised to $305 from $225 at Piper Sandler |
| September 9, 2026 11:17 am | — | UBS | $260.00 | $211.06 | TheFly | Illumina assumed with a Buy at UBS |
| September 3, 2026 11:48 am | — | Argus Research | $235.00 | $213.25 | TheFly | Illumina price target raised to $235 from $180 at Argus |
| August 3, 2026 11:06 am | — | Canaccord Genuity | $205.00 | $205.10 | TheFly | Illumina price target raised to $205 from $190 at Canaccord |
| July 31, 2026 2:09 pm | — | RBC Capital | $230.00 | $199.13 | TheFly | Illumina price target raised to $230 from $170 at RBC Capital |
| July 31, 2026 11:50 am | — | Bernstein | $215.00 | $205.09 | TheFly | Illumina price target raised to $215 from $185 at Bernstein |
Latest News for ILMN
SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference: Upcoming Investor Conference UBS Global Healthcare Conference on November 10, 2026 The fireside chat is scheduled for 07:15am PT (10:15am ET). The webcast can be accessed through the Events & Presentations section of Illumina's website at…
Rate and energy headlines have kept the broad market jumpy, yet one sector keeps finding buyers. Healthcare has led on days when the S&P 500 slipped, and the Nasdaq Biotechnology Index has pushed to record highs.
First Citizens Bank and Trust Co. purchased a new position in Illumina, Inc. (NASDAQ: ILMN) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,511 shares of the life sciences company's stock, valued at approximately $961,000. A number of
Illumina (ILMN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Krilogy Financial LLC lessened its holdings in shares of Illumina, Inc. (NASDAQ: ILMN) by 14.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,225 shares of the life sciences company's stock after selling 1,915 shares during the
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.